drug

tadekinig alfa

Phase 3updated 3mo ago

by AB2 Bio Ltd

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying tadekinig alfa

phase3Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiencycompletedn=15
phase3Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extensioncompletedn=11

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 35m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

tadekinig alfa

Phase 3updated 3mo ago

by AB2 Bio Ltd

Phase 3

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying tadekinig alfa

phase3Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiencycompletedn=15
phase3Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extensioncompletedn=11

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 35m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

tadekinig alfa

all catalysts(0)

Trials studying tadekinig alfa

News(0)

Report a data issue

comments(0)

tadekinig alfa

all catalysts(0)

Trials studying tadekinig alfa

News(0)

Report a data issue

comments(0)